Skip to content
sellWeak cluster of 510b5-1 plan

Michael Weintraub sold $537k of PHR

director at Phreesia, Inc.. 21,426 shares at an average of $25.05, traded Dec 13, 2024, filed Dec 17, 2024.

Warning score
14
Value
$537k
21,426 shares
Holdings after
242,827
-8% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $537k at market
    +19
  • Share of holdings sold
    Sold 8.1% of holdings
    0
  • Cluster
    5 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +7.8%, 3m +9.7%, 6m +2.7%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

PHROct 12, 2026 · close 10.82
Since filing Dec 17, 2024: -56.5%SPY +31.7% · excess -88.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001127602-24-029634, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 13, 2024MOption exercise
Common Stock10b5-1
+20,565$4.71$97k263,392Dec 17, 2024
Dec 13, 2024SOpen-market sale
Common Stock10b5-1
-20,565$25.04$515k242,827Dec 17, 2024
Dec 16, 2024MOption exercise
Common Stock10b5-1
+861$4.71$4,055243,688Dec 17, 2024
Dec 16, 2024SOpen-market sale
Common Stock10b5-1
-861$25.26$22k242,827Dec 17, 2024
Dec 13, 2024MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-20,565$0.00$017,748Dec 17, 2024
Dec 16, 2024MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-861$0.00$016,887Dec 17, 2024

Related signals

Other insiders at Phreesia, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
3Weak
PHRsell10b5-1
Phreesia, Inc.
Allison C Hoffman
General Counsel & Secretary
$67k
6,662 shares
-2%
3Weak
PHRsell 210b5-1
Phreesia, Inc.
Yvonne Hui
Principal Accounting Officer
$14k
1,247 shares
-5%
3Weak
PHRsell 210b5-1
Phreesia, Inc.
Lisa Egbuonu-Davis
director
$5,735
536 shares
-1%
3Weak
PHRsell 210b5-1
Phreesia, Inc.
Yvonne Hui
Principal Accounting Officer
$15k
1,371 shares
-5%
3Weak
PHRsell 210b5-1
Phreesia, Inc.
Lisa Egbuonu-Davis
director
$24k
2,546 shares
-6%
0Weak
PHRsell10b5-1
Phreesia, Inc.
Yvonne Hui
Principal Accounting Officer
$3,814
431 shares
-2%
17Weak
PHRsell 310b5-1
Phreesia, Inc.
Allison C Hoffman
General Counsel & Secretary
$56k
6,176 shares
-4%
10Weak
PHRsell 310b5-1
Phreesia, Inc.
Yvonne Hui
Principal Accounting Officer
$12k
1,327 shares
-5%
29Weak
PHRsell 310b5-1
Phreesia, Inc.
Yvonne Hui
Principal Accounting Officer
$91k
10,063 shares
-28%
20Weak
PHRsell 310b5-1
Phreesia, Inc.
Allison C Hoffman
General Counsel & Secretary
$117k
14,483 shares
-8%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.